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We investigated the regulation of C3 production by 
human cultured epidermal keratinocytes by enzyme-
Hnked hnmunosorbent assay. The results showed that 
IFNI' and TNFO' enhanced the synthesis of C3 by 
epidermal keratinocytes in a concentration-depen-
dent manner. Moreover, a protein kinase C (PKC) 
inhibitor blocked C3 production, whereas PMA en-
hanced it. There was a synergistic effect between 
IFNI' and TNFO'. In experiments to investigate the 
role of protein tyrosine kinase (PTK) in C3 produc-
tioIl; we found that treatment with herbim.ycin A, a 
specific inhibitor for the c-Src-related PTK, caused 
significant enhancement of the C3 production in-
I n gcneral, liver hepatocytcs are' r.egarded as th e major so urce of most complement compone n ts (A lper <,I ai , 19(9), but "O llle of these components are also synth esized at extra he-p~tic sites by other ce ll s ,mch as monocyrcs!macrophagl:s (S;]ckstein and Colten, '.1984; Hamilton ('( nl, 1987; K ulics CI 
nl, 1990), polymorphonuclear le ukocytes (Botto cI ai , 1992) fibro-
blasts (Katz ('( nl, 1999; Katz an.d Strun k, 1989) , endothe li al cells 
(Broo ill1 ~ns ('I ai, 1990; Lappin 1'1 ai, 1992), and epithe lial cells 
(Strunk el ai, 1988; 13rooimans (:1 (( / , ·'991 ; Andoh et ai, 1993). 
Human epiderma l keratinocytes Iwve also been reported as candi-
dates for local biosynth etic sites for C3 (Bass~t-Segll in eI ai , '1990) 
and f,1Cto r B (Yancey cl ai, ·1992). Because several hum oral faccors, 
in c ludin g cytokin es, regulate complemcnt syntheSis in the li ver 
(Permutter e/ nl, 198601: Perml1tter ('( ai, 1986b; R.amadori cl ai, 
1989) or o ther tissues, we assume that th ese factors might also 
participate in the regulation of complem ent synthes is III the skin. 
The regulato l'Y mechanisms involved in systemic or loca l com-
plement synthes is have been on ly partially e lucidated. for examp le , 
pro-inflam1llatol'y cytok in es, such as interieukin-1 (J L- ·I) , tumor 
necrosis £ilctor-a (TNFa), o r inrcrleukill-6 (IL-I) , were found to 
se lective ly in crease the synthesis of C3 or f:,<;tor B in hepatocytes 
(Pedlllu tter 1'1 ai, 1986a: Perlmutter cl ai , 1 'J86b; R.amadari 1'1 aI, 
1 () 88), human fibrobla sts (Katz Cl ai, ·1989; Katz and Strunk , 1989), 
and an intestin a l epithe linl ce ll line (Andoh 1'/ ai , ·1993). In another 
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duced by IFNI' or TNFa, suggesting that c-Src-typ~ 
PTK(s) provides a negative signal to C3 production, 
Each cOITlpetitive inhibitor of PTK, genistein or t~, 
phostin, substantially increased the C3 production b J\ 
IFNI' at lower concentrations, although each agen \ 
had little effect on TNFa-associated production ofC~ 
at the same concentrations. The data show that pro, 
inflammatory cytokines IFNI' and TNFa synergisti, 
cally augment C3 production by epidermal keratino, 
cytes by different pathways. Key lVords: C311/1111W11I 
itaatinocytelIFNylTNFO'. ] [livest Del"lltatol '1 08:62- 67~ 
1997 
-------------------.. 
study, in terferon- y (IFNy) was demonstrated to enh an ce the 
synth es is of C2, C4, and factor [3 (Kulics eI ai, ] 990; Lappin el ai, 
1992), althollgh it did not a llect the C3 production in hllJ11al) 
monocytes, flbroblasts, a hep;ttoma cell line (Lappin c( ai, 1992), o~ 
in 11mbilical vein endothelial cells (Brooimans et ai, 1990; Lappin e( 
ai, 1992). In the cu rrent study we designed a series of expe riments 
to inves tigate th e cytokine regulation of C3 production by hUlnal) 
epiderma l keratinocytes and to furth e r analyze the signal transduc_ 
tion pathways involved in the C3 production augmented by these 
cytokines. 
MATER.1ALS ANI) METHODS 
Chemicals and Reagents Huntan cytokines were purchased or pro-
vided as follows: IL-Icr, IL-l /3, IL-4, IL-6, Il-7, IL-8, TNFL' (Gellz),111e, 
Camhridge, MAl, IL- IO, transforming growth facwr-J3 1 (TGFJ31), grant!_ 
locyte-Ill:lcrophage colony -,rim ularin!; fa ctor (R & D Systems, Minneapolis, 
MN), Il-3, IFN/3, IFN I' (GIUCO Hili, Caithcrsblll"!;, MJ), IL-5 (Wako. 
Tokyo, Japan), TGFcr (l3oehrillger Mannileim GmbH, MannheiJlJ, Germa_ 
ny), and IFNcr2i1 (,. gift from Taked" Phannaceutical Co., Os;tk;t,Japan). AU 
t.he cyt o kin es. prep.ned at highe r con centratio ns in 0.1 (~I bovine sc ru1\'\ 
albumin-containing flhosphatc-bulfered saline, werc stocked Ht - 70°C and 
diluted jJ1 the COlllp1ctc J11cdiurn just before lise for tissue cultures. prJ{ 
inhibic()rs. hcrb il11 yci l1 A. geniste iIl , and ryrphostill. were obtained frQnl 
GIJ3CO BRL. A protein kinase C (PKC)-speciflc inhibi tor, R.o31-8220, was 
a gift fTolll Dr. Bradshaw of R.oche R.esea rch Center (London , UK). 
Phorbol myrisrate acetate (I'M A), forsko lin , and sodiulll onho-v;lnadate 
wC I'e purchascd from Si!;ll1a (St. Louis. MO). 
Culture of Epidermal Keratillocytes Human epidermal keratinocytes 
deri ved hom neon,ltal foreskin or adulr breast were obt" incd (i'orn C lonctics 
Corfloration (San Dic!;o. CAl and expanded ill 11lodified se rulll-fi'ce MCl3 D 
153 media (pH 7,4 , oSllloiltrity 340 ± 4 mOsm/ kg; 0. 15 mM Ca2 ~) , 
cOlltainin g growth f:lC: tors including bovine pituitary extract. or kcratil1 O-
ey re growth medium (KGM; Clonctics, San Diego, CA). The cells in the 
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F igure 1. IFNy and TNF(~ stimulate C3 production by c ultured 
human epidermal kcratinocytes, and the state of keratinocyte 
differentiation influences C3 production . Human epidermal kcrati no-
cytes we re expanded and treated in KGM containing low Ca 2 ' (0. 15 mM ) 
for 48 h with each cy tokinc: IL- Ia ( 100 U pc r ml ), IL-l {3 ( 100 U per ml ), 
IL-2 (200 U per 1111), IL-3 ( l O ng per ml ), I L-4 (200 U per ml). IL-5 (lOng 
per ml), IL- 6 (200 U pCI' ml) , IL-7 (1 () ng pe r ml), IL-8 (lO ng per m l), lL- 1 0 
(50 ng per ml), TNFu ( WO ng per ml), IFN n2a (200 U pCI' 1111) . IFN{3 (200 
U pcr 1111), IFNy (200 U pcr 1111), TGFa (lO ng per ml), TGF{3 1 ( I (] ng per 
m l) , o r GM-CSF (10 ng per ml). To induce keratinocyte difFe rentiation , 
ke ratinoeytes were incuba ted in KG M containing high Ca" (1. 2 111M ) fo r 
24 h. T hey were li.mher cultu red in the presence or absence o f each 
cytoki ne fo r 4!l h . T he supernatants were assayed for c., by ELI SA. C3 
p ro ductio n was ex pressed pCI' 10" viab le ke ra tinocytes (nanograms per 
m l/ l 05 ce lls) assessed by usc of tryp"n blue dye . Data arc mean ::!: SD. 
th ird passage we re cul tured in KGM containi ng low C a2 I (0. 15 mM) in 4R-
o r 24-wcll Aat-bottomed microtite r plates (Coster, C ambridge, MA) to 
atta in 70-80'1., conAuency. In thc 11rsI: experiment (Fig 1) SO llle of the 
kc ra tinocytcs w e re cultured in hi g h conce ll trat io ns o f C a2 ' ( 1.2 111M) fo r 
24 h to indu ce keratinocyte d ift'e rentiation and then treated w ith each 
cytokinc. 111 the reT1tai nin g ex pC r"irncllts th e y we re c ul tured in I< G M 
con ta ining low con ce n tratio ns of C al r- (0.15 InM ). Itt o the r espc rint e nts 
t hese kc ratin ocytcs ,vcrc pretreated \ov idl pro te in ki l1 :l se a11 rago nists o r 
ago nists fo r th e ind icated pe ri o ds of t im es . and they we re th c lI trea ted with 
each cytokin e . 
Sandwich Enzyme-Linked Im11111nOsorbcnt As.ay (ELISA) for the 
Quantification of C3 T he C3 con centrations in sam ples w e re quantifi ed 
by sand w ic h ELI SA. T he well s of 96-we ll fi at-bo tto med microtiter plates 
(Oym1tech La bo rato ri es, C hantill y. V A) were coated with polydonal goat 
anti-hu m an C3 ( lgC fi'actio n ; C appe l. West C hester, I'A) in a 50 111M 
carbonate / bicarbona te hu ffe r (pH 9.6) fo r 16 h at 4°C. After washing and 
blockin g o f nOl1 spec ific pro te in binding, rh e s:unplcs were inc uhated ill the 
w e ll s for 2 h at :I 7°C. Next, the we ll s were thorough ly was hed and 
incubated with peroxidase-labeled goat anti- hulll an C3 (lgG It'acti on ; 
Cappel) for 2 h at 37°C. C o lo r development of all sa tnples was performed 
using 1,2- 0-phenylened iall1inc di hydroch lo ride (Sigma, St. LOllis. MO) as a 
substrate . Ph osphate- buffercd s~t1in c con tai nill g 0.05'% Tween 20 w as lI sed 
fo r washing. T he ",1lount of the reacted subsrnlte was determin cd by 
01)4')2' Hig h ly puritied Illll1wn CJ (S igma, St. Lo u is, M O) was used as " 
standard. T he lower limi t o f thi s ELISA was I I) ng o f C3 pcr 1111. and no 
cross-reacti vity was detected ill feta l bovine serum . After the supenwWllts 
,ve rc rCJTtovcd rlt the end of each cytoki ll c t rcat l11 Cllt. c ul ture d kc ratin o c ytc s 
\\lcre treated with trypsin-cth ylc l1 cd iantinc tc traacetic ac id solutio n and the 
n umber of detached cel ls we re co unted . C3 production was expressed per 
105 viab le keratinocYles assessed b y usc o f rrypa n blue dye. All pharmaco-
logic age m s had li ttl e e lFeet 0 11 ke rati nocyte viab ility at concen trations used 
in this experiment. Eac h expe riment w;,s d one in tripl ic<lte and repeated at 
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Figure 2. lFNy and T N Fa increase C3 production by epidermal 
kcratinocytcs in a concentration-dependent fashion . Epidcnnal ke-
r<1ri n ocytcs c ultured ill K_GM con tai nin g: low C al + (0. 15 InM ) WL'rl' 
still1l1la ted w ith in creasing amounts o f e<lch cy tokine fo r 48 h: IFN I' (200 U 
per ml) , TNFa ( 100 ng pCI' ml ). T he "'pernatallts were ass<l )'ed fo r C:I by 
ELI SA. C3 productio n was ex pressed per 1 n" viable ke rati nocy tes assessed 
(nanograms per m l/ I OS ceil s) by li se o f tryp<ln hlue d ye . Da ra arc Incan ::!: 
SD. 
nrc sh o\vn in th e tigures. Espcrint c lttal d ;lta were ana lyzcd u sin g Stud e l1t 's 
t tcst. 
RESU LTS 
IFNy and TNFa Augment C3 Synthesis by Human Cultured 
Keratinocytes As J'eported b y another laboratory (J3asset-
Seguin et (/ I, 1990), cultured keratinocytes h ad the abi lity to 
p rod u ce C3 constitu tively. To determin e the effects of va ri ous 
cytokin es pro du ced b y huma n e pidermal kerati nocytes or infl am-
m a to ry ce ll s o n t h e syn th esis ofC3 , the ke ratinocytes were c u ltu red 
in KGM containing a set of growth f.1cto rs includi n g e pide rm al 
g rowth facto r and low Ca 2 " (0 . t 5 111M) fo r 48 h ill tI, e presen ce o r 
absen ce of cyto kines . O ur res ult s sh ow th at ke rarinoc tes produced 
C3 vigorously in th e prese n ce of TN Fa o r I FN -y (Fig 1). 
We a lso examin ed the influ e n ce of th e state of k e ratin ocyte 
differentiatio n . To indu ce ke ratinocyte d ifFe re n tiation, keratin o-
cytes were in c ubate d in KGM containin g hig h C a 2 I (J.2 mM) fo r 
24 h . T h e y w e re fi.lrt her c ulture d in th e pre sen ce or absence of each 
cytokin e , and data obtai n ed w e re compa re d w ith th ose o btained 
with KGM con ta inin g low C a" I (O . I S m M). T h e res ult (Fig t) 
sh owed th at th ey p rod uced hig h"" <lmOlllHs of C:I (p < 0.0 5) in 
hi g h Ca 2 + conditio n s, suggesti n g th at the sta te of keratinoC)' ("e 
differe ntia t io n influe n ces C3 pro du ction . In late r experim ents t h e 
ke ratin ocy tes were cultured ill KGM conta inin g low Ca 2 I (0. 15 
mM.) in the presen ce o r a b sence of cytokines. 
T h e e nha n cem ent b y TNFn o r IFN-y was found to b e co n cen -
n'acion depende n t (Fig 2). T h e result of ti m e course stud y sh owed 
tha t sma ll amo un ts ofC3 we rL' detec ted at 2 -+ h in respo n se to I FN y 
(200 U per 1111) or TNFO' ("100 ng per 1ll1), and th e prod u ction was 
in c reased co n sid e rably in the n ext 24 h (Fig 3). IL- l a: a n d IL- I {3 
h ad minute ell~c ts on ly at hig h con cen t ratio n s. Other cytokines 
sh owed n o influ e n ce on th e C3 prod u c tion b y k e ra t ino cytes a t even 
hi g her con cen t ratio n s t h an sh own in Fig 1 (data n o r sh ow n). 
The Cytokine Regulation of C3 Production by Keratino-
cytes Is Dependent on PKC Activity An in c re m e n t o f t h e 
Ca2 + co n cen tratio n ill th e c u lture m edium indu ces th e diffe r e nti-
atio n of ke ratin ocytes th rough PKC acrivatio n (Matsui ('I nl, 1992). 
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Figurc 3. IFNy or T NFa c nhanccs C 3 p rod u ction b y cpidc.rmal 
kcratinocytc~ in a timc-dcpcndcnt manner. Epide rmal kcrati ll ocy tes 
c ultured in KG M co ntai ning lo w Ca' l (0. 15 111M) were stimulated with 
TNFa ( IOD ng pc r 1111 ) o r IFN )' (200 U pcr rnl ) for 4H h . Th e su pcfIlat;um 
we re o hta ined at indic al ed time , as shown "nd """yed fur C3. C3 
pro ductio n w as expressed pc r ·10 ' viable keratinocy tcs (nanograms pe r 
mi l l O' ce lls). Data arc nICa n :!: SI) . 
In the first se t o f experime nts to in vestiga te the associa tion of the 
PKC-dependent pathway w ith the C 3 produ ctio n , we examin ed 
the effect of a hi ghl y se lec tive PK C inh ibito r , R 03 1-8220 , o n C3 
prod uction. Pre- treatm en t with thi s co mpo und fo r 1 h inhibi ted the 
C3 production induced by IFN)' o r TNFa in a co ncen tratio n-
d epe nden t manner (Fig 4), althou g h th i.s inhi b ito r had littl e effect 
o n keratin ocytc via b ility ;It con centrati o ns lI se d in th is experim en t 
(data not show n). W e also added a PKC agon ist, "M A, an d an 
aden ylate cyclase ac tivator , forskolin (0 .1 J.LM ), as a cA MP-depen-
dent k in ase agoni st to the cul tured keratin ocytes. PMA (0.1 J.LM) 
treatm e n t fo r 15 min in creased the C3 produ cti o n e nh an ced by 
I FN )' or T NFcr, w hereas fo rsko JjJI treatment for 1 h did not aftcCi" 
t he C3 p ro du ctio n (Fig 5) . 
I FNy and T N FO' Augment C3 Production by Keratinocytes 
Through the Activation of Different Sets of PTKs To 
fur the r ch ara c te rize the s i gn ~ 1 transducl:io n:i1 path ways to indu ce 
3 productio n by IFN )' and T NFa . we exam in ed wh e ther PTKs 
;lre assoc ia ted w ith the C3 produ ction indu ced by these cytokin es 
us in g three difi-c r(' n t ki nds of PTK inhi bito rs and a protein tyros in e 
p hosphata se inhibito r. sodillm vanadate. utilized as a PTK ago nist. 
H e rbim ycin A. a specifi c degradativc agent fo r th e c-Src-re latcd 
PT I( (Ueha r;, 1'1 (/1, 1989). gen istein , a competitive inhi bitor fo r the 
A T Il- h indin g site of PTK (Ak iya ma l'f (/ /,1 987), ;md tyrphostin . a 
competi ti ve inhi b ito r f() r t he substrate bin d in g site of PTK (Gnzit ('I 
(/1, 19H9), were te ted fo r tlteir inhi b ito ry ac tiv ity o n th e C3 
productio n by keratin ocytes. 
H e rbimycin A treatm e n t of keratin ocytes fo r 1 () h enhanced the 
C3 prod ll c tion in a co nce n trati o n-depend enl- fa shi o n (Fig 6a) , 
sugges ti ll g tha I: a c-Src r;,mi ly of PTK prov ides a negative sign al to 
C3 pro du ctio n . In te restin gly, pre- in c ubation of e pid erma l kera ti-
n o cytes w ith geniste in fo r ·1 h o r with tyrph ostin for ·1 CJ h showed 
diffe re nt e1lect, o n th e C3 pro du ctio n indu ced hy LFN)' o r TNFa 
(Fig 6/1, c). Hig h co nce n tratio ns of ge nistein and ty rph os tin exerte d 
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F ig ure 4. A selective PKC inhibitor, Ro31-8220 blocks C3 produc, 
t ion b y e pidermal keratinocytes. C ultured kcratinocytcs ill KGM collta.in. 
ing low C a2 ' (0.1 5 mM) were pretreated with R.o3 1-8220 for ·1 h and 
subsequen ti )' cultu red for 48 h ill the prcscllc,; of lFN ), (2UO U pcr .... 1) Or TNFn 
( 100 ng per ml) . C3 prod uction was assessed by ELISA and e xpressed pcr 10' 
viable keratinocytes (nanograms pcr ml / I 0 ' ce ll s) . Data arc mean :!: SD. 
a slightl y inhibi to ry efFect on th e in cre ase in C3 production by IFN )' 
o r TNFcr. O n the other hand, at lowe r concen trations both 
inhi bitors enh an ced th e C 3 produ cti o n indu ced b y IFN),. but n ot 
that by T NFcr (F ig 6b,c) . Treatllle nt o f epidermal keratino cytcs 
w ith a prote in ty rosin e ph osph atase inhibi to r, sodiulll vanadate, for 
6 h e nhan ced th e C3 production in a con centratio n-dependent 









0 50 LOO 150 200 250 
C3 production (ng/ml/IO 5cclls) 
F igure 5 . PMA c nha n ces thc C3 production b y IFNy or TNFa. 
Epidcnrwl kc ratino cytcs cultured ill KG M conta ining low C "2-' (0. 15 mM ) 
we re pretrea ted w ith PMA fo r 15 min o r fo rsko lin fo r I hand fin:thcr 
c ultured fo r 48 II ill [he presen ce 0 1' absell ce of IFN y (200 U per m l) or 
TNFa (100 II g pe r ml) . T he supe rnatants we re assayed fo r C3 by ELISA. C 3 
productio n "vas expressed per 105 viabk k e rati nocy tcs ( ll t1 n ogra Il1S per 
ml / 10' ce ll s). Data are m ean :': SD. 
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Figure 6. IFN I' and TNF(r au gment C3 production by different PTK-associated signal t ransdu ction pathway(s) . HI.1I11 ;1I1 epidermal 
kcratin ocytcs wcre expallncn alln pretreated with either I'TK antagollist or agollist for the fo ll owillg times ill KGM comai ll ill[.': low e a" ' (0. 15 1l1M ). PTK 
inh ibi to rs: herbilll ycill A (a) alld cr rp hosri ll (h) fo r 1(, h alld ge lli stei ll (c) lor I h: a proteill I) 'ros ille phosphatase illhi hi ro r. sodi llm va lladate. was lisen as a 
PTK a!,;ollist (d) for 6 h. The), wcre fi llThcr clIltlll'ed ill the prese ll ce ofIFNy (2 011 U per ml) or TNF<! CI 01) II g per 1111 ) fo r ·I l) h. T he slIpcl'llatanrs were assayed 
for C3 by ELI SA. CJ production was cxprcsscn pcr III ' " iah lc keratinocytes (nall ograllls per mil lO' ce lls). Data arc mean ± Sf). 
f.,s hi on (Fig 6d). indi cati n g that th e m o dul atio n of C3 pl'Odu c tion 
b y IFNI' o r TNFcx is associated with PTK ac tivity. From this and 
o th e r stud ies , wc assumc that difl-erent se ts of PTKs w ith differe nt 
a ffinitie s against these PTf( inhibito rs are in volved in th e C3 
prod uc tion indu ced by IFNI'. All an tagoni sts and agonist h ad li ttle 
e ffect on kc ratinocytc viabili ty and constitu t ive pro duction of C3 
(Figs 6a-d) at concen tratio ns use d in thi s expcrime n t. 
IFNI' and TNF(~ Synergistically E nhance C3 Production by 
Keratinocytes T he resul ts o r th e prev iou s experimen ts sug-
gested that IFN y and TNFcr enh anced C3 prod uc tion by ke ra tino-
cytes th ro ugh difFe ren t pathwa ys. In th e n ext c xperimen t we 
investigated w hethe r I FN l' an d TN F (~ exert a syncrgisti c e flect o n 
the C3 production by keratinocytcs . Keratiu ocytes were pre-
in cubated at first with o nl y a small am o unt (8 U pe r 1111 for IFNI' or 
4 ng per ml for TNFa) of either one of these cytokines fo r 1 hand 
furthe r in cubated w ith diffe ren t conce ntrations of th e othe r or the 
sa m c cytok in e fo r the n ext 48 h , as shown in Fig 7 . COlllpa red w ith 
the res ults of the C3 produ c tio n in du ccd b y a sin g lc cy tokin c . e ithe r 
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Figu1"e 7. IFNy and TNFlI' ha ve a syn ergistic effect 011 C3 produc-
tion by epidermal keratinocytes. Epidermal kerarill oc),res were ex-
panded in J<GM cOllmini llg low Ca 2 f (0 . 15 mM). T hey were pre-rreared 
with" slllall alllo lili t o f e ither c)' tok ine (8 U pcr 1111 for IFNy o r 4 nil' per 1)11 
for TN Fa) for I h and further incubarcd with ill c ,'cas ing all10ullts of tire 
oth e r or the S;alllC c)rtokinc for the next.:l8 h . The supc.rn ;\t:111 ts \vcr\!. assayed 
for C3 h)f ELISA, C3 p rod ll ction was expressed per 10 ' via hie kcratinocytes 
(nallograllls pCI' ml / I 0' ce ll s), I)a"a arc I11call :!: SI) , Pre trcatm en t: D. not 
rrealcd: 1Zl. IFN 'Y (8 U pCI' ml): •. TNFo' (4 ng pCI' 1111 ). 
treatment com bined w ith a different cytok in e ca used a marked 
en hancemen t, almost rea ching tw ice that attained w ith a sin gle 
cytok ille treatmen t (Fig 7). O n the o ther hand. combination 
treatment with the sa me cytokine showed o nl y an additive e ffect 
(Fig 7) , These resul ts also support the observ;ttion that the C3 
p"oduction is not induced th rough th e sa m e signal transductio n 
pathway(s). 
D ISCUSSION 
T here is accum ulatin g evide nce that epidermal keratinocytes can 
ini tiate and propagate immuno logic and inAanlll1 atory reactions 
th rough the action of c)'tokin es they secrete. In the curren t study, 
we demonstrated that pro-in Aal11ll1atory cytok in es I FN Y or TN Fa' 
cnha ll ce tI'e production of an illlpo rta nt complement component. 
C3 . by epidermal keratinocytes. In this experim ent we have 
evalu ated C3 p rod uction by an E LISA m ethod. The re are p ublished 
data (Yancey el al. 1992) showing that C3 produccd b y epiderma l 
keratillocytes co rresponds structurall y and fun ctionally to C3 found 
in plasma studied by diWe rent methods. 
IFNy can irreversibl y inhibi t ke ratinocyte proliferation (Saunders 
and Jetten , t 994), T he inhib ition of ke ra tillocyte growth by I FNy 
is acco mpallied b y a rcm arka b/e red uctio n in the ex pression of 
severa l growth contro l genes, In addition to IFNy. I-here arc several 
facto rs thnt inliuence ker:Hinocyte g row th. Among them, ep ide rmal 
growth hlctor, TGFa'. and IL-G arc known to sti mul ate the 
pro li feration of epidermal ke ratinocytes . Conversely, TGFt31 in-
duces reversihl e growth arrest in ep ide rnwl keratinocytes (Geo rge 
1'1 nl, I 99(), Our resul t showed that epiderma l growth facto r . 
TCFa, IL-6. and TCFt31 were not fou nd to inAuellce C3 produc-
tio n, indi cating that the signa l ITa nsd uctional path way for C3 
prod uction is 11 0t necess;lI'il y assoc ia ted with the signal for cell 
g rowth. 
Severa l fa ctors, including e kvation of Ca2 I , PKC, retinoids. and 
lFNy, ha ve been shown to inAue nce ep idermal difFerentiation. 
Uec;\ usc phorbol ester-mcdiared activatio n of I'KC induces squa-
mOllS differentiation in epid ermal keratinoc)'tes (Y uspa cl nl, 1982; 
T H E JOUR.NAL OF INVESTIGATIVE DER.MATOLOGY 
Reinel'S and Slaga, 1983) , the induction of squamo us differentiation 
by l FNy could be m ediated by the activation of PKC. In our 
experimen ts we de mon strated that C3 production was associated 
with ke/'atillocyte differentiation because pre-incubation of kerati-
nocytes in a high Ca2 + conditi o n o r additio n o f a PKC agonjst 
enhanced C3 production, whereas a PKC an tagonist inhjbi ted the 
production effectively, indi cating tha t th e C3 production induced 
by IFN )' is dependent on PKC activation . 
TNFlY is known to be produced by epid ermal keratinocytes 
(Kock ('( (1/, 1990) as well as by macrophages and lymphocytes. The 
binding of TN Fa to its recepto rs triggers the activation of several 
second messengers through stimulation of PKC (Brenner et a/, 
1989), sphin gomyelinase (Yang ct nl, 1993), and phospholipase A2 
(1-laY:lkawa el ai, 1993) . Cell exposure to TNFa also results in 
N F"B activation (Lenardo and Baltimore, 1989) and stimulati o n of 
AP-1 activity (B"enl1er et nl, .1 989; Westwick l't ai, 1994). We found 
in this study that C3 production by TNFn was inhibited by a PKC 
inhibitor. whe reas production was enh anced sign ifi ca ntly by a PKC 
agonist. PMA, supporting the idea that the C3 production induced 
by TNFn is dependent on the activ;lti o n of PKC. 
We showed that 1L-'1 a and 1L- 1 f3 had minute effects 0 11 C3 
production at their high con centrations. The effects were variable 
between different skin donors. Altho ugh we could not obtain 
concl usive data in the c urre n t study, the age of skin donors and 
cul ture conditions may inAuence the C3 production . It is also 
known that IL-J production by keratinocytes and its function are 
complex and arc regulated. as shown by Kupper (rev iewed in 
Kupper, 19(0). T hus, We aSSum e that several factors might m od-
ulate C3 production through the regulation of the expressio n of 
IL- t recl!pto r on keratinocytes o r the pro ductio n of I L-l receptor 
antagonist (Big ler CI ai , 19(2). 
Phosphorylation of proteins on tyros in e residues is a key bio-
chemica l reactio n that m ediates numerous cellular signals , includ-
in g the contro l of the ce ll cycle alld cel l differelltiation (Hunter and 
Cooper. '1985). T here is a report describing the inhibito ry eWect of 
PTK inhibitors, tyrph osti ns, 0 11 the proliferation of cultured no rmal 
human keratinocytes (Dvir el nl. 199 1) . A Ca 2 -1--sensitive PTK 
causes keratinocytes to dilFerentiate via subsequent PK C activ'ltj on 
(Filvaroff el "I, 1994). It is also known that twO different PTKs, 
c-S rc . and c- Yes. which is a member of c-Src-type PTK. are 
associated with ke ratinocyte differentiation; i.e .. in proliferating 
keratinocytes, c-Yes kinase activity is sustained and the signal of 
keratinocyte differen tiati o n in;lctivates its activity . O n the other 
b;lIld , the differentiatio ll sig nal res ults in the cnhan ceme nt of c-Src 
activity (Zhao ct nl, 1993), although the precise m olecul ar m echa-
nism is still not known. T he results of o ur study show that a 
degradation of c-Src- type PTKs by herbim ycin A ca use a sign ificant 
en hance m ellt of C3 pro du ction by keratinocytes induced by IFNy 
or TNFa. suggesting that c-Src-type 1'TI«s), possibly c-Src, pro -
vides a ll eg;lti ve signal to the C3 production. 
Although we demonstrated in this study that PTK activ'lrion 
plays a pivota l role in the lFN y- o r T N Fa-induced C3 production. 
ex perim ents conducted with the PTK inhibito rs, geni stein. and 
ryrph ostin , sh owed quite different results, Doth inhibito rs sli ghtl y 
reduced the TNFa and IFN y-associa ted production ofC3 at high er 
con cen trations. Interes tingly, the augm en tation of C3 produ ctiol1 
by IFN y was in creased "ather vigoro usly at lower concentrations. 
We also dem onstrated that IFN y and TNFa: exerted a synergisti 
effect o n C3 production by keratinocytcs, suppo rting the idea that 
differ -' nt PTKs are in vo lved in the pathway for C3 production 
augmente d by IFN )' and T NFn, 
T he epidermis, the outerm ost layer of the skin, is not m ere ly a 
barrier, but actively exe rts a pro-inAal11lllatory fun ction through 
secretion of va ri ous m od ulato '·s, incl uding not on ly cytokines and 
peptide factors bu t also compl emen t components. We demon-
strated he re that the pro-inflammatory cytokin es, lFN y and TNFn. 
augment the C3 production by epide rm:,l ke,·atinocytes synergis ti-
call y. We think that, in pathologic conditions, where levels o fl FNy 
and TN Fn are elevated in the sk.in, complement activation by 
in vad in g mic,·oorganisrns or stratum corn cum (Terui c/ nl. 1989: 
VOL. 108. NO. JANU ARY 19')7 EN H ANCEMENT OF I<EI,-ATINOCYTE C3-PRODUCTION BY IFN I' AND TNF" 67 
Terui cl nl, :\995) easi ly occurs to attack thcse microorganisms or to 
facilitate the formation of aseptic subcornca l pustules. We believe 
that the present findings lead to a better understanding of thc 
defense mcchanism against microorganisms and the pathogencsis of 
severa l sterile pustular dcrmatoses. 
~VC Ihallk Ms )'lIlIIik" Yos hill{) Jill' ski/Ifill Icchllica/ I/ssiSII/II{/·. T his SIIU/), ",as 
slIpporled ill parI b)' S hiscido FOlllldlllioll .Ii". Skill A.~illg Resellrch IIl1d /J)' 
CrllI ll-ill-Aid SciCli,.,' Rescareh, N os. 06-15-13U, 0780 70 79, alld 08-15723-1ji'olll 
Ihe Ntillist/), .if Edll(lltioll, S( il'llc(', IIl1d C II/Illre, jllpall. 
REFERENCES 
Akiya ma T, Ishida J. Ntlk<1~.nY .. S, Ognwara H. \ '\Iat'lIIilbc S, lcoll N. Shibu )'a M. 
Fukal1li Y: Genistein, a spec ific inh ihiror of tyrosill c-spccifl(.' protein kill:tscs. 
) Bioi ChclII 2(,2:5592-55')5. 1987 
Alper CA. Joiln soll AM, Birtch AG, Moor FD: I-Itlman C3: evidence le r the li ver as the 
pri lll ilry site of synthesis. SCit'II((' 163:286-288 . t c)6~ 
Andoh A. Fl1.iiy~lIna Y . B:ll llba T. Hosoda S: DitlcrClll-ial t:ytokiuc rcgui:ltio tl of 
co mpl cment C3 . C4, alld RlCtor I3 sYllthesis ill 1!l1l1lall intestinal epithelia l cell 
Line. Cacu-2.) 1111111111",1 151 :4239-42·17. I ~,)3 
Basset-Seguin N. Ca ug llll'l i.l1l SW. YallCl~y KB : A-431 ce ll s :lnd hUI1I:l1l kerarin ocvtes 
synth csize and secrcte rhe th ird cOI llponell1 o f cOl1lplcmellt . .J ( ,,/I/'SI D(,fII~(Jrol 
95:62 .1- 625. 199U 
Bigler CF. Norris DA. Westoll WL. Arend \'\/P: Ill lCrleukill- 1 receptor <lntil gonist 
pro dut.:tio n by human kcr.lI:inocytcs.J IlIl lt'Sf DrnllflhI/9B:3H-4-1. 1992 
Botto M. lissandrini D. Sorio C, Walport MJ: lliosYT1tlicsili ,md secrcrion of comple-
m ent componenl (C3) by acti vated human pul ynlOrphulluciear Icukocy[cs. 
) 1""'"1"01 149: 134H- 1355. 1992 
Brenncr DA. O 'Hara M. Angel P. Chojkier M. J<llrin M: Pro longed activation ofjull 
and collagenase gencs by tunto ur necrosis factor-a. N{/(lIrt' 337:66 1-0(.3. '1 !.IS9 
Orooil1lans RA. Sl"egm:1II1I AP, Vall Dorp WT. Van Ocr Ark AA. Van Ocr \X/Olinde 
fJ. Van Es LA. D'lila Mit: Ili terieukin 2 Ill cdia tes stiIllulatioll of complemellt C3 
biosynthesis in hUIlWIl pro ximal tuhula r ~pithc li;tl t:c lh . ./ e li" fllIlI'st g~:371)-384. 
1991 
I3rooil11ans I'-A. Van Del' Ark AA. Buunnan WA. Van Es LA . Daha Mit: Differentia l 
r'.!gu i:l tion of co mplcmcllt f~lI.; tor 1-1 and C3 production ill human umbili cal vein 
endothelia l cell s by IFNI' and IL-I.) 11I""'1I1I>/144 :3~35-384 (}, 19<)(J 
Dv ir A. Milner V. C ho m sk y O. Gilon C. G:lz it A. Levitzki A: The illilibitio l1 or 
EGF-dcpClldell t proliferation of kcratinocYl"cs by r)'rp hosti n ty rosi ne killas~ 
blockers.) Cdl Wal 11 3:857-865. 1 9~ 1 
Filvaro ff E. C nl :llItti E. Reiss M. Dorto G P: Functiona l e"idem;:c tor an extracellular 
c.t1ciul1I reeepmr mcdwllism tr iggering tyrosine kinasc activation associated with 
mou.se keratinocytc differentiation. J /Jilll C ltelll 269:2 1735-2 17 .. W. 199 -1 
Gazit A, Va ish P. G ilon C. lcvitzki A: TYI'p hostins I: synthesis :1I1d bio log ical activity 
of protein tyrosi ne kinilse inhibi tors. J ,Hed CI,t'1II 32 :234 -1 -2352 . 19R9 
George MD, Vollberp; TM. Floyd EER. Sleill .Ill . J cttC Il AM: Iteg ular:ion of transglu-
taminase lYpc II b y transfo rming growth r.,c.:tor-t31 ill lIormal and lransformed 
IUII11:111 epidcrmal kerat in ocytes. J Bitl! C ltt'/II 265: I 1098 -I 11 0 4. 1990 
Hamilton AO, Jones L. Morrison l. Wha le y K: Modulatio n of l11o lloL"yte compleme llt 
synthesis by interfe ro ns. WI>eh"", I 2 4 2:~1I9-H 15. 1987 
Hayakawa M. Ishida N. T,lkclIChi K, Shiballlow S, Hori S. O ku N. Iro F .. TSl~j ill1 ot() 
M : ArachidolliL" ;\cid-sclcctive L"yrosolic phospholipase A2 is c ru cial ill r.lle 
cytotox ic action o ftlllllor nccrosis factor.) iJiol C"l'1I1 2M): 1 1290-1 1295. 1993 
Hunter T. Couper JA : Proccill ryrosinc kin;) ses. A IIIIII UI'I' Bi(wlu'", 54:H97-'J30. 1 98~ 
Katz Y. Reve l M. Sl"runk R C: In tcrl eukin () stimulates synthesis of complemenr 
proteins fa ctor U ;lIId C3 in human skin ti hro hlasts. Ell,.) III/WI/I/O! 1 9:983-98~. 
1989 
Katz V. Strunk RC: I L-I and tumor necrosis f:u.: ror: s ill1i1arit'i~ s ;md differcnces ill 
~('il1l lllarion of ex prcssi 0 11 ol";l lrernarive p;llhw;IY ot"co mplt!lllcnr and IFN-I3,:! / IL-6 
ge nes in human fibrob lasts. J //IIlIlIlI/C 11 1-1 2:38G2-3~67. 1989 
Kuek A. Schwarz T .. Kinlball er l-t. Urbanski A. PL'rry P. Anscl J C. Lug.n TA: Htl1ll :1Il 
keratinocytes arc :1 source for Illl110 r ncc.:rosis f:lcror 0': E,"idence for synthesis :lI1d 
rcle3sl! II pon sti mula tion w irh enoo[(}x in or IIl tra"iolct liglll. J EXJl j\ll'ti 172: 
I GUY - 16 14 . I Y90 
Kulies J . Co lrel1 HR. Pcrlmutl"er DI-I: COli ntcrreglll:uory cffct.: t :" of illtcrfernn-l' and 
l'lldomxi ll O il exp ressioll Oe dle human C .. I ge nes. J e li" hl/' est 85:943-1)49. 1990 
Kupper TS: TIl l~ a c tiv~l"l'd kL'rarin ot:)'tl':": A mode l for inducihle cytok inc producriOlI by 
nOIl-bo ll e marrow-deriv cd cell s in C ll Ulll~OUS inA allllt1:lwry :l1ld illlllll111C rl'-
spUllses. J (/lPl 'Sf Dl'rmilfcl! 94: ·146S- 150S. 1990 
Lappin OF. GliC D . Hill A. M cS hanc T. \Xlhalcy K: Effi..'c r of inrcrfcro ll -Y O il 
co mplemell t gene expressiotl in diflcrcllt ce ll rypes. Bic,rhcJltJ 2H I :437--1-12. I C)') 2 
len.lI·do MJ. Balrill10re D: Nr:-K13: ;1 plciorropi c lIledia ror of inducihle ilnd lissue-
specifiC gene t:onrrol. r.cll 58:227-2_l). 19HC) 
Mal sui MS. CIH~W SL. Delco VA: PrOle in kinase in 110rmal IHllllatl epidcrma l 
kcr;llinocYlcs durin g proli feration ;lIld calci um -indu ced differentiatio n. J !" I'L'st 
Dl'r/llI1(I)/ 99:565-571. 1992 
Pcrll1luuer DH. Dinarcll o CA. PIIIIsal PI. C ohen Hit: C:H: hcctinllulllor necrosis fa ctor 
regulates hcpa tit.: anne-phase gene exprcssio n .J Cli" {/ll ll's t 78: 13-49 -1354. 19H6a 
Perllllutte r DH. Go ldberger G. Di nare l1 0 CA. Mizcl SO. Colten HR: Rcgu lation of 
c lass III InajaI' Ilistocol1lpatihiliry compll!x gene products b y ill rerleukin-I . SciC' //rl ' 
232:850 - 852. 1986b 
Ralllildori G. Van OOllIlIllC..I. I"t.iedcr 1-1 .. Mcycr Z Ulll Uu st:henfcldc KH: IlIl"erie ukin (,. 
tlte third m ed iator OfaClIl"C-phll se reaction. m o dulates hepatic protei n synrhc:" is ill 
human and mo use: Comparison wid. illt c rleukin t {3 and tll1ll0r necrosis r:1ClOr-tr. 
/ ;'urJ IIIIII/II/IeI! I H: 12::;'J- 1264. 1988 
R e incrs Jr .JJ . Siaga TJ: Effects of rU1110r promol'ers 011 the rafe and rommi[lllelH" to 
terminal diUcrell l'j:ltioll of'suhpo pnlariolls of lIlurine ker:llinoc),n:s. Cd! 32:2-17-
255. 1Y83 
Sackste in R. Coh en H1'-: Molecu lar regulation or MH C da" III (C4 and lactor B) 
gene expression ill m o use perilUll cal l1lanoph a~c!! . ./ III/Il/l'"II! 13.1: I () 1 H-162h , 
1'184 
S'Hll ldcrs NA. Jerico AI'V\: C onrrol of g rowth rcgul:II'ory and ditfcreT1tiati("lll-spccifk 
genes in IlI.11I1 :l n cpidermal k~ratilloc)'tc s by i11lerferon 1'. An tagonism by reti no ic 
acid and transforming growth f:lclor (3 1. J H;,,! C /iCI/I 269:20 16-2022. 199 -1 
Strunk ftC. Eidlen DM. Mason RJ: Pulmonary c1 vcol:lr type II cpithelia l cc lls 
s)' l1l'hcsize and secretl' prote in s of IIl e l:1a ssiC:IJ and ;;tlrerll :lli,'c complemcllt 
parh w;\ys.J CIi" 1111 1(~SI X1: 1-11 9-1-I 2(,. 19BB 
Tcrl1i T. KaLO T. Tag:1I1 li H: SI:r:1l1t11l co rnelllll activarion of compl c llI c lH rhrollg"h thL'. 
antihody-indcpcndent a ll crnat'ive p:H!t W:ly . ..III11IC .. \·( Dl'rlll (ltol 92:593-597. 1989 
Terui T, Z hcll V-X. Kat o T, Tag-ami H : Mechanism oj" human poIYll1orphollllcll!:lr 
le llkncYl"c adhl!sion 10 scrlllll-rreatcd co rn eoc), lL'S. J 1I11'('st OC",,,,"II! 10-1 :297-30 I. 
1995 
Ue hara Y. Fuka zawa H. Murakami Y .. Mi zull o S: Irreversible inhihitioll o f v-s rt" 
rrrosinc kinase ~c(ivit)· by hcrbil11 ),cin A and its ahrogation by Stlrfl lydryl 
compounds. fJi,'(/n'lII lJiophp' nt's e lll/JIII//ll 163:S03-809. 1989 
\'\/estwick JK. \Veiezc l C. Minden A. Karin M. Bre l1ncr DA: TUllIor l1t.'c rosis r.1CWI' (t' 
Slill1ul:ncs AP- I activiry through prolonged :lnival:ion ofrhc c-JUI1 kin:lSl' .j Bit" 
C ite", 2G '!:263%-26·IOI. 1994 
Yan cey J<13. Ove rhl'llscr O . I o llll oge- I-lult"sch N. Li L-J. Cllugltman S\X'. 13isalbt1rra P: 
Hum an keratinot:ytcs :lnd A-~31 cells s)'111l1 csize ;md secrele faC IOr 13. rhc lIt:1jor 
zymosan Pl'orcllse o r the a lrcrnari ve C0 l11plCI1lCl11 pmllway. J (1I1 'cst O/T/,,"IO! 
98:37~-383 . 1992 
Ya ng Z . COSI"an20 M. Golde 0\'\1. I<olesnick P....N: Tumor Ilccrosis f:lcror acriv:nioll of 
thc sphingornye lin path way sign;ds nu clea r f~lcf(lr k.B transloc:I!:Ioll ill illla n 
I-IL-(,O cell s. ) l3i,,1 C ite", 26M:20S20-2052J. I Y93 
Vuspa SH. t3en T. H c nllill !,?;s H. Lkhit U : Pho rbo l csler rul110r proll1oter .. indllcc 
epidermal transg-htl:1I11i~llase activit")' . 13;(1( 111'/11 Hi0l'''rs {~l'J COl li 11/1111 ~7:700-7(1~. 
1')H2 
Z ha o V. Uyu"cndacle H . Krucger ..J G . Sudol M. Hall :l fu sa H : In aniv:llioll of c-Vcs 
ty rosin e kinase by elevatio n of illira ccl llll:ir calc iulI1 Icvels. 1\101 Cell BioI 
1J:7607-75 14 . 1')')3 
